Support 100 years of independent journalism.

  1. Science & Tech
  2. Coronavirus
20 April 2020updated 06 Oct 2020 9:45am

Plasma from Covid-19 survivors to be trialled as coronavirus treatment in UK

By Samuel Horti

The NHS will collect blood plasma from people who have recovered from Covid-19 so that it can be used as a potential coronavirus treatment.

Trials will investigate whether plasma therapy, which relies on antibodies stored in the plasma of a previously infected person being transfused into a different patient, could help protect against the virus. 

“If fully approved, the trials will investigate whether convalescent plasma transfusions could improve a Covid-19 patient’s speed of recovery and chances of survival,” a spokeswoman for the blood service said.

“We are working closely with the government and all relevant bodies to move through the approvals process as quickly as possible.”

Those who have recovered from Covid-19 can sign up to donate their blood plasma.

Sign up for The New Statesman’s newsletters Tick the boxes of the newsletters you would like to receive. Quick and essential guide to domestic and global politics from the New Statesman's politics team. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. A handy, three-minute glance at the week ahead in companies, markets, regulation and investment, landing in your inbox every Monday morning. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A weekly dig into the New Statesman’s archive of over 100 years of stellar and influential journalism, sent each Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy